Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
|Videos|October 22, 2014
Challenges Ahead for Specialty Pharmacy
Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.
Advertisement
Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.
Advertisement
Related to this article
Doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd (Voceryq) targets HPV-6 and HPV-11 to reduce the surgical burden for adults with recurrent respiratory papillomatosis, a rare airway disease.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
2
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
3
Survodutide Shows Cardiovascular Safety in SYNCHRONIZE-CVOT
4
How Pharmacists Help Patients Spot Patterns in Glucose Readings
5